Treating Blood Cancers

Hannah Levavi, MD, Tisch Cancer Center at Mount Sinai Hospital, New York, NY

Recorded on September 24, 2026

Hannah Levavi, MD

Assistant Professor of Medicine, Division of Hematology & Medical Oncology

Tisch Cancer Center at Mount Sinai Hospital

New York, NY

In this episode, join Dr. Hannah Levavi from the Tisch Cancer Center at Mount Sinai Hospital, as she explores the evolving landscape of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Dr. Levavi reviews the clinical presentation and key diagnostic features of BPDCN, along with current first-line treatment approaches. She also examines the role of stem cell transplantation and discusses emerging therapies, including targeted agents and CAR T-cell therapy. The episode concludes with a look at ongoing research and future directions aimed at improving outcomes for patients with BPDCN. Tune in for this informative discussion on this rare hematologic malignancy!

Blood Cancer United Resources:

Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education

Blood Cancer United Resources for Patients

Jason Domogauer, MD, PhD, NYU Perlmutter Cancer Center, New York, NY

Recorded on August 27, 2026

Jason Domogauer, MD, PhD

Director, LGBTQ+ Cancer Care and Research Program, Perlmutter Cancer Center

Assistant Director, Community Outreach and Engagement, Perlmutter Cancer Center

Director, Community Outreach and Engagement, Department of Radiation Oncology;

Assistant Professor, Department of Radiation Oncology

NYU Langone Health

New York, NY

Join us for an insightful conversation with Dr. Jason Domogauer from NYU Perlmutter Cancer Center as we explore the unique challenges and disparities faced by LGBTQI+ individuals across the cancer continuum. Dr. Domogauer discusses the psychosocial, clinical, and communication needs of LGBTQI+ patients with cancer, as well as strategies for delivering inclusive, affirming care. He also shares approaches to fostering welcoming healthcare environments, and highlights resources for both clinicians and patients. Tune in to this thoughtful discussion on advancing equitable, patient-centered cancer care.

Mentioned on this episode:

Cancer Network

Fenway Institute

Kone

Blood Cancer United Resources:

Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education

Blood Cancer United Resources for Patients

Ramy Sedhom, MD, FASCO, University of Pennsylvania, Plainsboro, NJ

Recorded on August 13, 2026

Ramy Sedhom, MD, FASCO

Associate Professor, Clinical Medicine, Division of Hematology/Oncology

Director, Program in Geriatric Oncology & Supportive Care Innovation and the

Center for Cancer and Aging at the Penn Center for Cancer Care Innovation

University of Pennsylvania

Plainsboro, NJ

In this episode, Dr. Ramy Sedhom from the University of Pennsylvania explores the role of bereavement support in oncology care. He discusses how clinicians can support patients’ families after a loss, recognize when grief may require additional intervention, and incorporate meaningful bereavement practices into routine care. The conversation also examines the impact of patient loss on healthcare professionals and offers practical strategies to reduce clinician moral distress and burnout. Tune in today for this thoughtful conversation!

Mentioned on this episode:

The Journal of Palliative Medicine: Top Ten Tips on Bereavement Care

Man’s Search for Meaning by Viktor E. Frankl

It’s OK That You’re Not OK by Megan Devine

Blood Cancer United Resources:

Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education

Blood Cancer United Resources for Patients

Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN

Recorded on June 23, 2026

Stephen Ansell, MD, PhD

Division Chair, Hematology

Mayo Clinic

Rochester, MN

Join Dr. Stephen Ansell from Mayo Clinic for an in-depth discussion on Waldenström macroglobulinemia, focusing on the latest advances in diagnosis, treatment, and management. This episode explores clinical features, the importance of molecular markers in guiding diagnosis and treatment decisions, and current indications for initiating therapy. The discussion also addresses the management of IgM-related complications, emerging therapeutic approaches, and future directions in care. Listen to this exciting and informative episode today!

Blood Cancer United Resources:

Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education

Blood Cancer United Resources for Patients

Marina Kremyanskaya, MD, PhD, Icahn School of Medicine at Mount Sinai, New York, NY

Recorded on June 2, 2026

Marina Kremyanskaya, MD, PhD

Associate Professor

Tisch Cancer Institute

Icahn School of Medicine at Mount Sinai

New York, NY

Join Dr. Marina Kremyanskaya from the Icahn School of Medicine at Mount Sinai in this expert discussion on mastocytosis, including an overview of the disease, key signs and symptoms, and current diagnostic criteria with a focus on relevant genetic mutations. She discusses recently approved therapies, emerging treatment approaches, and ongoing clinical trials that are shaping future treatment. The episode also covers approaches to managing complications, addressing treatment-related side effects, and delivering patient-centered care.
Don’t miss this informative episode!

Blood Cancer United Resources:

Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education

Blood Cancer United Resources for Patients